Member Info for TrickyEFC

Skid n co need to learn crying and moaning over one company for years ain't how ya play this game

Hope this flies for any holders.

Am out again. New uncle is skid still here 😂😂

You knows it llama

Same for the 5 million seller.

💪💪

Doors and move up a lil again 😁

Nutts academic research seems golden so far and we far from having an absence of solid intellectual property.

In-vitro screening for SERT, DAT, and NET release - Evotec appointed by Awakn to lead key preclinical testing.

To ensure the highest standard of preclinical validation, Awakn has appointed Evotec, a globally recognised leader in drug discovery and development, to conduct in-vitro screening for SERT, DAT, and NET release activity.

Evotec brings world-class expertise in:

· Neurotransmitter pharmacology

· High-throughput screening

· Precision drug discovery

Evotec's analysis will provide critical insights into the candidates' ability to modulate neurotransmitter release, a key mechanism underpinning AWKN-SDN-14's therapeutic potential.

This in-vitro testing phase, which builds on the positive animal testing results, is expected to be completed by the end of July 2025, aligning with the revised Programme timeline

The involvement of academic research in drug discovery is consistently growing. However, academic projects seldom advance to clinical trials. The high attrition rate of drug discovery projects in the CNS field within academia is often due to the lack of meaningful animal models that can provide pharmacological proof-of-concept for potentially disruptive technologies at the earliest stages, and the absence of solid intellectual property. Source below

https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.202400397

As it stands market cap is £11,210,000

chips

No daffy it can't its going to thew 03s :p

not today though lol

The plums spot on again

just so i am not singling one poster out.

skid n finger up my own **** just as bad.

maybe not dl but the market has provided several chances to trade some of ya losses back but alas not they just moan more n more about dl. good luck to all still in.

Twib mate exman last post

But my conclusion is that you have been done by DL.

Making out like he ain't be nuked by DL. He been here long long time not a happy camper.

'is that you have' not including itself. Fantastic stuff.😂

Will companies from all these different sectors be coming to Solvonis for advice and data in the not so distant future regarding the CNS info we have?

The patent, expected to be granted in the coming months, will confer U.S. exclusivity through to at least 2043, reinforcing the long-term value of Solvonis' early-stage pipeline.

May need a bigger bUilding lol

While the primary focus is on CNS, morpholine derivatives have a history of use in various other therapeutic areas, including antiviral, antibacterial, and anti-fungal treatments, as well as in agrochemicals.

The library may include food crops??

These RNs just get juicer n jucier

A family of novel morpholine-class compounds is being developed, particularly for applications in central nervous system (CNS) therapies, with a focus on depression, stimulant use disorder, and other neuropsychiatric conditions. These compounds are part of a new chemical space being explored for CNS treatments, potentially offering new therapeutic options for these conditions.

More details:

Novelty:

These compounds are described as "novel morpholine-class compounds," indicating they represent new chemical structures within the morpholine family.

Focus on CNS:

The research and development efforts are primarily directed towards treating central nervous system disorders, including depression and stimulant use disorder.

AI-supported development:

The compounds were initially developed with the support of artificial intelligence (AI) technologies.

Intellectual Property:

The claims in the patent cover both the composition of matter (the chemical compounds themselves) and their methods of use, providing broad protection for the innovation.

Wider Applications:

While the primary focus is on CNS, morpholine derivatives have a history of use in various other therapeutic areas, including antiviral, antibacterial, and anti-fungal treatments, as well as in agrochemicals.

Morpholine Structure:

Morpholine is a six-membered heterocyclic ring containing both nitrogen and oxygen atoms, making it a versatile scaffold for medicinal chemistry.

Examples of Existing Morpholine Drugs:

Several approved drugs contain the morpholine moiety, including antidepressants like moclobemide and reboxetine, and the appetite suppressant phendimetrazine.

⏰⏰⏰⏰ and at some stage 💣💣💣💣💣💣

Correct llama we have a LIBRARY

The CNS library, which includes multiple chemically distinct, preclinically validated series, underpins Solvonis' AI-supported drug discovery platform. The patent adds meaningful protection across novel CNS chemical space, especially in depression, stimulant use disorder and other neuropsychiatric conditions.

..

Crazy time to sell. Hope they get burnt bad by this avo 😊

This 5mill seller been a busy boy

Peculiar action this morning